Neem, LLC

About Us

Our Vision

The Indian Neem tree is fast-growing and thrives even in difficult conditions. Like the rapidly growing Indian Neem tree, Neem was founded to be synonymous with spurring fast growth in science and technology.

Our Mission

Neem brings great ideas to market through collaboration with science and technology innovators utilizing a comprehensive healthcare and financial network.

Founders and Neem Advisors

Steve Hanley founded Neem LLC in 2009 along with two experienced partners. Neem was formed to take advantage of the founders’ unique but diverse backgrounds and desire to help breakthrough products reach the marketplace. We work with start up companies, universities, individual inventors, and venture capital firms.

Steve Hanley – Principal and Founder

Steve is an experienced global business leader who has managed highly complex pharmaceutical and medical device operations with annual global revenue exceeding $1 billion.

As the President of Covidien’s Imaging Solutions business unit, he led a multifunctional organization that included sales, marketing, logistics, manufacturing, as well as research and development. Steve led Covidien Imaging Solutions in 2007 and 2008 to high single digit revenue growth with rapid expansion outside of the United States. His leadership included guiding investments in new products and technologies.

Over his nearly 18 years with the Covidien family of companies, Steve developed a large network of business leaders and clinicians to help determine market needs, commercial potential and product positioning. As a sales leader, Steve called on radiologists, nuclear medicine physicians, cardiologists, as well as surgeons in specialties including general, orthopedic, and OB/GYN.

Internationally, his track record includes numerous new drug and device product introductions and sales force expansion in Eastern Europe, China and Latin America. Steve is experienced working in different cultures and successfully navigating dynamic regulatory environments.

Since founding Neem in 2009, Steve has worked with numerous companies to help establish their long-term strategic goals and better identify the opportunities and risks ahead. In addition to his strategic expertise, several of Steve’s clients utilize him as lead negotiator to maximize the value of their technology and increase global reach of their products.

Steve is currently on the Board of Advisors for Check-Cap, a diagnostic company located in Israel.

He has his bachelor’s and master’s degrees in business administration from Marquette University.

Terence Stern – Practice Lead

Terence is a global executive with a proven record of entrepreneurial achievement in start-up, private equity, and publicly owned companies across a range of life science ventures in multiple international geographies.

Terence served as Chief Executive Officer and Founder of Vetbrands International. Vetbrands was a private equity backed management buyout of Ralston Purina’s pharmaceutical business. His lead role through the process enabled combination of Cargill owned assets with the independently owned pharmaceutical / R&D facility in Brazil.  Successful orchestration of multiple acquisitions, the subsequent merger, integration, and growth led to sale of the top ten Brazilian animal pharmaceutical business to Ceva Santé Animale at the end of 2007.

In 2010 Terence led negotiation of the joint venture resulting in the first human supplement ingredient acquisition for Novus International. In Terence’s general management role Novus’s leading global nutrition specialty business profitably doubled sales through organic growth. His leadership resulted in approval of significant incremental investments including a dedicated production facility and bolt-on acquisition.

Terence has developed detailed investment theses and financial models for Neem clients and subsequently validated these with leading healthcare focused private equity firms. A recent example is development of a consolidation strategy for servicing a range of diagnostic imaging modalities.

Terence has demonstrated the ability to solve complex business challenges in collaboration with highly technical life science collaborators. His approach is logical, creative, and benefits from a broad perspective gleaned from conducting business in 26 countries over the course of his career. Terence is fluent in French, Portuguese, and Spanish.

He has his bachelor’s degree from Colgate University and a master’s degree in business administration from Washington University in St. Louis.